featured
Empagliflozin as an Adjunct to Insulin Therapy in Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
Diabetes Care 2018 Oct 04;[EPub Ahead of Print], J Rosenstock, J Marquard, LM Laffel, D Neubacher, S Kaspers, DZ Cherney, B Zinman, JS Skyler, J George, N Soleymanlou, BA PerkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.